View More Recent Stories
-
Elanco Animal Health (ELAN) Misses Q4 EPS by 1c, provides guidance
-
Elanco Animal Health (ELAN) Enters Agreement with Medgene to Commercialize Highly Pathogenic Avian Influenza Vaccine in Dairy Cattle
-
Elanco Animal Health (ELAN) Launches Pet Protect From the Makers of Advantage
-
Meet the Faces of Zen: Elanco's Zenrelia(TM) (ilunocitinib tablets) Helps Allergic Dogs Get Back to Normal
-
UBS Starts Elanco Animal Health (ELAN) at Buy
-
Elanco Animal Health (ELAN) Falls 8%
-
Leerink Partners Starts Elanco Animal Health (ELAN) at Market Perform
-
Elanco Animal Health (ELAN) Acquires Speke Contract Manufacturing Facility, Securing Key Supply Chain
-
Elanco Animal Health (ELAN) Appoints Stacey Ma to its Board
-
Elanco Animal Health (ELAN) Tops Q3 EPS by 1c, provides guidance
-
Elanco Animal Health (ELAN) Receives FDA Approval for Credelio Quattro
-
TD Cowen Reiterates Buy Rating on Elanco Animal Health (ELAN)
-
Stifel Reiterates Buy Rating on Elanco Animal Health (ELAN)
-
Piper Sandler Reiterates Neutral Rating on Elanco Animal Health (ELAN)
-
Elanco Animal Health (ELAN) Announces FDA Approval and Launch of Zenrelia, Offering An Effective, Safe Solution in Canine Dermatology
-
Stifel on Elanco Animal Health (ELAN): 'Zenrelia Approved - What We Currently Know'
-
Morgan Stanley Downgrades Elanco Animal Health (ELAN) to Equalweight
-
Elanco Animal Health (ELAN) Provides Update on Contract Manufacturing Partner
-
Increasing unusual call option volume: LUNR MFC NMM K VIPS GOGO WB ELAN COMM COTY LUMN ACI PSEC YUMC
-
Elanco Animal Health (ELAN) Announces Credelio Quattro Moves to Final FDA Administrative Review
-
Elanco Animal Health (ELAN) January 13 and 14 calls spreader active
-
Elanco Animal Health (ELAN) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY24 Guidance
-
Elanco Releases 2023 Environmental, Social and Governance Report, Delivering Healthier Outcomes for Animals, People, Planet and Enterprise
-
Elanco Animal Health (ELAN) Completes Sale of Aqua Business to Merck (MRK)
-
BofA: Top 10 US Ideas for Q3 2024
-
Elanco Animal Health (ELAN) PT Lowered to $16 at Piper Sandler
-
Increasing unusual call option volume: ELAN WOOF LOGC FFIE LEVI
-
Elanco Animal Health (ELAN) Issues Innovation Update

